Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $22.50 price target on Achillion Pharmaceuticals (NASDAQ: ACHN) following yesterday's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE